NEWS
Study Finds Small Increase in Cancer Risk after Childhood CT Scans
A new study shows that radiation exposure from computed tomography (CT) scans in childhood results in very small but increased risks of leukemia and brain tumors in the first decade after exposure. The study, led by researchers from NCI and Newcastle University, is the first analysis of CT scans that looked at exposed patients directly instead of using models based on atomic bomb survivors or other populations accidentally exposed to large doses of radiation. Read more > >
For Some Breast Cancers, New Drug May Be Treatment Option
T-DM1 prevented cancer progression longer and produced fewer side effects
Preoperative Chemotherapy, Radiation Improve Survival in Esophageal Cancer
Neoadjuvant regimen now widely adopted as standard therapyFor Some Skin Cancers, Targeted Drug Hits the Mark
Vismodegib benefits certain patients with basal cell carcinomaStudy Suggests New Treatment Option for Some Lymphomas
Patients receiving a new combination lived twice as long without their disease progressingStudy Shows First Effective Drug for Cancer Patients with Peripheral Neuropathy
Duloxetine reduces painful side effect of chemotherapy in some patientsAlso in the News: Even Low Doses of Radiation in Childhood Raise Breast Cancer Risk
Also in the Journals: Global Cancer Burden Expected to Shift
COMMENTARY
A Conversation with Dr. Patricia Steeg on Redesigning Clinical Trials to Test Therapies that Could Prevent Cancer Metastasis
The head of the Women's Cancers Section in NCI's Laboratory of Molecular Pharmacology argues that the current system for clinical trials must be redesigned if there is to be a decline in breast cancer metastasis.
IN DEPTH
Expanding the Playing Field: Immune-Based Therapy Shows Potential for Lung, Other Cancers
In some patients, responses to the treatment lasted at least a year
Featured Clinical Trial: Adjuvant Everolimus for Resected Kidney Cancer
Will taking everolimus after surgery delay recurrence of renal cell cancer?
Charting a Course to Genome-Guided Cancer Medicine
At NCI workshop, experts discuss bringing DNA sequencing into the clinic
UPDATES
FDA Update
- Pertuzumab Approved to Treat Some Metastatic Breast Cancers
Cancer.gov Update
- Cancer Control P.L.A.N.E.T. Portal Gets New Look
Notes
- NCI's Barnett Kramer Named ASCO Fellow
- NCI Advisory Boards, Director's Consumer Liaison Group to Meet End of June
- Free Workshop for Cancer Survivors: Changing Roles and Responsibilities of Caregivers
- Workshop to Focus on Integrating the "Omics" into Biology, Clinical Care
- NCI's Tom Misteli Wins Flemming Award
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
